Shopping Cart
- Remove All
- Your shopping cart is currently empty
5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 of 33.4 nM, suitable for studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease, or gastrointestinal disease [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $38 | In Stock | |
10 mg | $58 | In Stock | |
25 mg | $119 | In Stock | |
50 mg | $197 | In Stock | |
100 mg | $322 | In Stock | |
200 mg | $455 | In Stock | |
1 mL x 10 mM (in DMSO) | $42 | In Stock |
Description | 5-HT2B antagonist-1 is an orally active 5-HT2B receptor antagonist with an IC50 of 33.4 nM, suitable for studies of diseases characterized by 5-HT2B receptor signaling, such as hepatocellular carcinoma, cardiovascular disease, or gastrointestinal disease [1] [2]. |
In vitro | 5-HT2B antagonist-1 (compound 5g) exhibits sodium channel binding activity with IC50 values ranging from 12.6 to 57.5 μM [1] and inhibits 5-HT2B receptor activity by less than 50% at 1 μM in CHO-K1 cell lines (compound 1-e) [3]. |
In vivo | The oral administration of 5-HT2B antagonist-1 (compound 15) at a dosage of 30 mg/kg significantly reduces visceral hypersensitivity in irritable bowel syndrome (IBS) rats [2]. |
Molecular Weight | 296.17 |
Formula | C11H14BrN5 |
Cas No. | 393129-91-4 |
Smiles | CC1(C)NC(Nc2ccc(Br)cc2)=NC(N)=N1 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.